Concepedia

Daniel Lama

DL

14

Publications

876

Citations

12

H-Index

2001

Active since

Affiliations

University of California, Irvine(Current)

Stanford University

Hadassah Medical Center

Cleveland Clinic

University of Cincinnati Medical Center

Daniel Lama is an author at University of California, Irvine specializing in medicine, urology, and urogynecology.

ORCID

Top concepts

Publications per year

2001–2024

14

Publications

14

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Rodney A. Appell, Peter K. Sand, Roger R. Dmochowski et al. · Mayo Clinic Proceedings · 2001 · 245 citations

, , +6

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Rodney A. Appell, Peter K. Sand, Roger R. Dmochowski et al. · Mayo Clinic Proceedings · 2001 · 201 citations

, , +6

PENTOSAN POLYSULFATE SODIUM THERAPY FOR MEN WITH CHRONIC PELVIC PAIN SYNDROME: A MULTICENTER, RANDOMIZED, PLACEBO CONTROLLED STUDY

J. Curtis Nickel, John B. Forrest, Kevin M. Tomera et al. · The Journal of Urology · 2005 · 137 citations

A multicenter, prospective, open-label study of tolterodine extended-release 4 mg for overactive bladder: The speed of onset of therapeutic assessment trial (STAT)

Paul Siami, Larry Seidman, Daniel Lama · Clinical Therapeutics · 2002 · 51 citations

, , +6

Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: A subanalysis of data from the OPERA trial

Franklin Chu, Roger R. Dmochowski, Daniel Lama et al. · American Journal of Obstetrics and Gynecology · 2005 · 36 citations

, , +7

Rows per page

1–5 of 14